期刊文献+

2010—2012年首钢水钢总医院抗菌药物应用分析

Analysis on The Antibiotic Use in Shougang Shuigang General Hospital During 2010-2012
下载PDF
导出
摘要 目的:了解我院抗菌药物的使用情况,分析其临床使用的合理性,为合理使用抗菌药物提供参考。方法:对2010—2012年我院抗菌药物销售金额、用药频度(DDDs)、限定日费用(DDC)和排序比(B/A)等进行统计和分析。结果:我院抗菌药物的销售金额及占药品总销售金额比例、抗菌药物使用率及抗菌药物使用强度(AUD)呈逐年下降趋势。结论:我院抗菌药物使用情况基本合理,但仍然存在不合理的问题,需进一步加强抗菌药物应用的管理和培训,提高抗菌药物的合理用药水平。 OBJECTIVE:To investigate the antibiotic use in our hospital, analyze the rationality of the clinical antibiotic use for references of rational use of antibiotics. METHODS: The consumption sum, DDDs, defined daily cost (DDC) and B/A (order ratio ) of antibiotics in our hospital during 2010-2012 were analyzed statistically. RESULTS: The consumption sum of antibiotics in our hospital and its proportion in total drug consumption sum, the rate of patients administered with antibiotics and the antibiotic use density (AUD) all showed downward trend. CONCLUSION : The antibiotic use in our hospital was generally rational yet it is far from perfect, thus it is important to strengthen management and training on antibiotic use to improve the rational level of antibiotic use.
出处 《中国医院用药评价与分析》 2013年第10期877-879,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 抗菌药物 用药频度 限定日费用 Antibiotics DDDs Defined daily cost(DDC)
  • 相关文献

参考文献7

二级参考文献32

  • 1段蕴铀.浅谈呼吸道感染中抗菌药物的临床应用[J].中国药物应用与监测,2005,2(1):17-19. 被引量:9
  • 2张致平.抗生素结构修饰的进展[J].中国抗生素杂志,2006,31(2):90-99. 被引量:9
  • 3刘家健.头孢菌素类品种研发与生产现状探讨[J].中国抗生素杂志,2006,31(2):100-106. 被引量:16
  • 4苏建荣,马纪平.实验室开展厌氧菌检查的重要性[J].中华检验医学杂志,2007,30(1):12-13. 被引量:11
  • 5Jack J C, Theresa M B, Joseph T W, et al. Randomized, prospective comparison of first-and second-generation cephalosporins as infection prophylaxis for cardiac surgery[J]. Am JSurg, 1993, 166(6): 734-737.
  • 6Stuart M H. Pharmacokinetics of the third-generation cephalosporins[J]. Am J Med, 1985, 79(2): 21-24.
  • 7Emirhan N, Sedef K, Doruk K, et al. Simultaneous roultiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: Application to validation and quantification of cefepime, cefixime and cefoperazone[J]. Talanta, 2009, 80(1): 117-126.
  • 8Yoshizawa H, Kubota T, Itani H, et al. New broad-spectrum parenteral cephalosporins exhibiting potentactivity against both methicillin-resistant Staphylococcus aureus(MRSA ) and Pseudomonas aeruginosa. Part 2: Synthesis and Structure-activity relationships in the S-3578 series[J]. Bioorg Med Chem, 2004, 12:4211-4219.
  • 9Gasink L B, Fishrnan N O, Weiner M G, et al. Fluoroquinolone- resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact[J]. Am JMed, 2006, 119(6): 526.
  • 10Tomoyasu I, Shohei H, Yuj I. Phosphonocephem derivatives, process for the preparation of the same and use thereof [P]. US 6417175 B1, 2006-07-09.

共引文献268

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部